Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?

Despite the availability of a lot of effective disease-modifying drugs, multiple sclerosis (MS) (in particular the progressive forms) still represents an important unmet medical need, because of issues in terms of effectiveness, duration of response, safety, and patient compliance. An increasing bod...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Brancati, Serena, Gozzo, Lucia, Longo, Laura, Vitale, Daniela Cristina, Drago, Filippo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2021
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290177/
https://ncbi.nlm.nih.gov/pubmed/34295328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.661882
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk